Ergoloid Mesylates is used in the treatment of alzheimer's disease (brain disorder that affects memory and intellectual ability), stroke (decreased blood supply to brain), dementia in parkinson's disease (a disorder of the nervous system that causes difficulties with movement and balance), age related memory loss and head trauma
How it works
Ergoloid mesylates act centrally, decreasing vascular tone and slowing the heart rate, and acts peripherally to block alpha-receptors. One other possible mechanism is the effect of ergoloid mesylates on neuronal cell metabolism, resulting in improved oxygen uptake and cerebral metabolism, thereby normalizing depressed neurotransmitter levels.
Common side effects
Vomiting, Gastrointestinal disorder, Lightheadedness, Loss of appetite, Running nose, Nasal congestion, Stomach upset, Tongue ulcer, Warm sensation
- 1 variant(s)